To clarify the possible role of HIF-1α in the antitumor effect of emetine in human NSCLC cells, CL1-0/CDDP cells were treated with 10 μM cisplatin only, 40 nM emetine only, or a combination of cisplatin and emetine. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.